4.8 Review

Cyclin E in normal and neoplastic cell cycles

Journal

ONCOGENE
Volume 24, Issue 17, Pages 2776-2786

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/sj.onc.1208613

Keywords

cyclin E; Cdk; cell cycle; tumorigenesis

Funding

  1. NCI NIH HHS [R01CA102742, R01CA84069] Funding Source: Medline
  2. NHLBI NIH HHS [K08HL073670] Funding Source: Medline

Ask authors/readers for more resources

Cyclin E- Cdk2 has long been considered an essential and master regulator of progression through G1 phase of the cell cycle. Although recent mouse models have prompted a rethinking of cyclin E function in mammals, it remains clear that cyclin E impacts upon many processes central to cell division. Normal cells maintain strict control of cyclin E activity, and this is commonly disrupted in cancer cells. Moreover, cyclin E deregulation is thought to play a fundamental role in tumorigenesis. In this review, we discuss the regulation and functions of cyclin E in normal and neoplastic mammalian cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available